Oncolinx Competitors and Similar CompaniesClear all

Oncolinx's competitors and similar companies include Captor Therapeutics, Moleculin Biotech, Biocon and Kyowa Kirin.
Oncolinx
Oncolinx
Oncolinx is a company developing antibody-drug conjugates (ADCs).
Captor Therapeutics
Captor Therapeutics
Captor Therapeutics is a biopharmaceutical company focused on the development of protein degradation drugs for cancer and autoimmune diseases.
Moleculin Biotech
Moleculin Biotech
Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates.
Biocon
Biocon
Biocon is a company that develops and manufactures biopharmaceutical products.
Kyowa Kirin
Kyowa Kirin
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
Founding Date
Founding Date
2013
Founding Date
2017
Founding Date
2006
Founding Date
1978
Founding Date
2008
Type
Type
Private
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
HQ
Locations
Wrocław, PL HQ
Allschwil, CH
Locations
Houston, US HQ
Locations
Bengaluru, IN HQ
Bengaluru, IN
Nanakramguda, IN
Dublin, IE
Kuala Lumpur, MY
Puchong, MY
Delémont, CH
see more
Locations
Tokyo, JP HQ
Sydney, AU
Shanghai, CN
Prague, CZ
Tampere, FI
Düsseldorf, DE
Hong Kong, HK
see more
Employees
Employees
3
Employees
88
Employees
176% decrease
Employees
16,5612% increase
Employees
5,669
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
7.5 m
Valuation ($)
N/A
Valuation ($)
8.8 b

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
₹167.8b (FY, 2026)
Revenue (est.)
¥496.8b (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
₹56.9b (FY, 2026)
Cost of goods
¥114.3b (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
₹115.8b (FY, 2026)
Gross profit
¥383.4b (FY, 2025)
Net income
Net income
N/A
Net income
N/A
Net income
($33.6m) (FY, 2025)
Net income
₹3.7b (FY, 2026)
Net income
¥67b (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 1.1m
Total funding raised
N/A
Total funding raised
$ 491k
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Captor Therapeutics
HQ
Wrocław, PL
Employees
88

Captor Therapeutics is a biopharmaceutical company focused on the development of protein degradation drugs for cancer and autoimmune diseases.

View company
Moleculin Biotech
HQ
Houston, US
Employees
17↓ 6% decrease

Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates.

View company
Biocon
HQ
Bengaluru, IN
Employees
16,561↑ 2% increase

Biocon is a company that develops and manufactures biopharmaceutical products.

View company
Kyowa Kirin
HQ
Tokyo, JP
Employees
5,669

Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.

View company